See also this year's filing and all EDGAR filings for this company.
PDF Report 0001516079_2017_US_China_Biomedical_Technology_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | No stock price available | subcommand.plot | {} |
| warning | Missing logo | subcommand.report | {} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 9.805171247315835e-07, 'aggregate_val': 1019869, 'exp_sum': 1019870, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingAndMarketingExpense': 40000, 'GeneralAndAdministrativeExpense': 302257, 'remainder_Expenses': 677613}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0001516079, US China Biomedical Technology Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 0 |
| 1 | AssetsNonCurrent | 0 |
| 2 | IntangibleAssets | 0 |
| 3 | PropertyPlantAndEquipment | 0 |
| 4 | remainder_Assets | 2,855 |
| 5 | LiabilitiesCurrent | 30,666 |
| 6 | LiabilitiesNonCurrent | 0 |
| 7 | remainder_Liabilities | 0 |
| 8 | CostOfGoodsAndServicesSold | 0 |
| 9 | SellingAndMarketingExpense | 0 |
| 10 | GeneralAndAdministrativeExpense | 56,169 |
| 11 | remainder_Expenses | 800 |
| 12 | remainder_Revenues | 0 |
| 13 | remainder_NetIncome | 0 |
| 14 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,855 |
| 1 | Liabilities | 30,666 |
| 2 | Expenses | 56,969 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -27,811 |
| 5 | NetIncome | -56,969 |
| 6 | ComprehensiveNetIncome | -56,969 |
| 7 | BaseVar | 45,245 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -4.69 |
| 9 | EconomicCapitalRatio | 0.00121 |
Edgar->Model Mapping
Feature Distribution
Change over Time
